Currently recommended treatment regimens for human monocytic ehrlichiosis (HME) include doxycycline or tetracycline. Antibiotic susceptibility studies demonstrate that rifampin has in vitro bactericidal activity against Ehrlichia. Case reports have suggested clinical response with rifampin treatment of human granulocytic anaplasmosis (HGA). We report the first case of HME successfully treated with rifampin.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744069 | PMC |
| http://dx.doi.org/10.7759/cureus.444 | DOI Listing |
Publication Analysis
Top Keywords
treatment human
8
human monocytic
8
monocytic ehrlichiosis
8
successful treatment
4
rifampin
4
ehrlichiosis rifampin
4
rifampin currently
4
currently recommended
4
recommended treatment
4
treatment regimens
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!